Cyclin B1 Peptide-Pulsed Autologous Dendritic Cell Vaccine for Resectable Non-Small Cell Lung Cancer

NCT01398124 · clinicaltrials.gov ↗

NA

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped We will not be pursuing this study.

Conditions

Non-small Cell Lung Cancer

Interventions

BIOLOGICAL: Cyclin B1 Peptide

Sponsor

Milton S. Hershey Medical Center